Mangoceuticals, Inc. (MGRX) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Healthcare Information Services industria. La empresa tiene su sede en Dallas, TX, United States. El CEO actual es Jacob D. Cohen.
MGRX tiene fecha de IPO 2023-03-21, 3 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $4.09M.
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
